Global Therapy Monitors
For today’s leading pharma and biotech companies, Global Therapy Monitors needs no introduction. We’ve been delivering real-world patient data, layered with HCP perceptions, for over 30 years – guiding decisions big and small across the product lifecycle.
We pride ourselves on the quality, reach and global comparability of our data – but it’s how we activate it that sets us apart…
Each Global Therapy Monitor subscription comes with the benefits and cost efficiencies of multi-client research, but with bespoke analyses and recommendations from experts in that disease – all tailored to your business questions and strategy.
About Global Therapy Monitors:
• Real-world patient treatment data layered with HCP perceptions
• Data trended wave on wave over years & decades (30+ years in some diseases)
• Operational excellence and a globally consistent methodology
• Bespoke analysis & recommendations from therapy area experts
• A reduced compliance burden due to the independence of datasets
• Insights applicable for myriad business questions & multiple client teams.
Diseases covered
Global Therapy Monitors run in oncology, obesity & cardiometabolic diseases, virology & vaccines, immunology, neurology and rare diseases.
Recent thought leadership
PoV: Finding their position: Where GLP-1s fit in cardiorenal care
Clinical poster (ADA 2026): Diabetes Status and Comorbidity Burden Shape GLP-1 Treatment Decision-Making
Public Report: Global consumer perceptions on obesity
Clinical poster (ACC 2026): Sex-Specific Systemic and Phenotypic Patterns in Transthyretin Amyloid Cardiomyopathy: Insights from Four Years of Multinational Data
Webinar: Advances in Metabolic Therapeutics for Obesity, Diabetes and MASH
Connect with our therapy experts today.
